ACLOT PHARMA
ActiveSummary
ACLOT PHARMA has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €127k and a net result of €47k. Equity is growing by ~3.4% per year across the filed fiscal years. Its solvency ranks better than 21% of 6537 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability73▲+5
Solvency34=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 3.06 against 2.78 in 2023; short-term debt: 10.8% and cash: 12.4% of total assets), but 90.8% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 6537 sector peers (2024).
NBB · sector comparisonPosition among 6537 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-07-2025, 27 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
27 d early
2023
30 d late
2022
3 d early
2021
4 d early
2020
31 d late
2019
89 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€47k
2023 · €-7k
2018: €8k
2019: €-3k▼ -140% vs 2018
2020: €-240▲ +92.9% vs 2019
2021: €-4k▼ -1399% vs 2020
2022: €25k▲ +807% vs 2021
2023: €-7k▼ -126% vs 2022lowest in 7 years
2024: €47k▲ +799% vs 2023highest in 7 years
2018 → 2024
Working capital
€306k▲ 30.2%
2023 · €235k
2018: €149k
2019: €146k▼ -1.9% vs 2018lowest in 7 years
2020: €193k▲ +32.3% vs 2019
2021: €281k▲ +45.7% vs 2020
2022: €194k▼ -31.1% vs 2021
2023: €235k▲ +21.5% vs 2022
2024: €306k▲ +30.2% vs 2023highest in 7 years
2018 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€105k-€101k▼ 3.4%€127k▲ 25.2%€120k▼ 5.3%€127k▲ 5.8%
2020: €105k
2021: €101k▼ -3.4% vs 2020lowest in 5 years
2022: €127k▲ +25.2% vs 2021
2023: €120k▼ -5.3% vs 2022
2024: €127k▲ +5.8% vs 2023highest in 5 years
Operating result€5k-€6k▲ 17.1%€36k▲ 497%€4k▼ 90.1%€59k▲ 1,564%
2020: €5k
2021: €6k▲ +17.1% vs 2020
2022: €36k▲ +497% vs 2021
2023: €4k▼ -90.1% vs 2022lowest in 5 years
2024: €59k▲ +1564% vs 2023highest in 5 years
Net result€-240-€-4k▼ 1,399%€25k€-7k€47k
2020: €-240
2021: €-4k▼ -1399% vs 2020
2022: €25k▲ +807% vs 2021
2023: €-7k▼ -126% vs 2022lowest in 5 years
2024: €47k▲ +799% vs 2023highest in 5 years
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 1,564% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.38M
Fixed assets
€928k ▼ 10.1%
Current assets
€455k ▲ 23.9%
Equity and liabilities €1.38M
Equity
€127k ▲ 5.8%
Debt
€1.26M ▼ 1.8%
Debt's share of the balance-sheet total falls from 91.4% to 90.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€163k▲
2023 · €110k
Cash flow
€151k▲
2023 · €99k
Current ratio
3.06▲
2023 · 2.78
Quick ratio
1.56▲
2023 · 1.14
Debt to equity
9.91▼
2023 · 10.68
ROE
37.1%▲
2023 · -5.6%
ROA
3.4%▲
2023 · -0.5%
Interest coverage
15.81▲
2023 · 10.71
Debt ≤ 1 year
€149k▲
2023 · €132k
Debt > 1 year
€1.11M▼
2023 · €1.15M
Income taxes
€2k
Staff costs
€193k▲
2023 · €188k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 52 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.40M€1.38M▼
Fixed assets21/28€1.03M€928k▼
Tangible fixed assets22/27€1.03M€928k▼
Land and buildings22€385k€369k▼
Plant, machinery and equipment23€647k€559k▼
Financial fixed assets28€140€140=
Current assets29/58€367k€455k▲
Stocks and contracts in progress3€217k€223k▲
Stocks30/36€217k€223k▲
Amounts receivable within one year40/41€52k€61k▲
Trade receivables40€3k€2k▼
Other amounts receivable41€49k€58k▲
Cash at bank and in hand54/58€99k€171k▲
Equity and liabilities
Total equity and liabilities10/49€1.40M€1.38M▼
Equity10/15€120k€127k▲
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k-
Reserves not available under the articles1311€2k-
Distributable reserves133-€2k
Profit (loss) carried forward14€99k€106k▲
Amounts payable17/49€1.28M€1.26M▼
Amounts payable after more than one year17€1.15M€1.11M▼
Financial debts170/4€437k€397k▼
Other amounts payable178/9€711k€711k=
Amounts payable within one year42/48€132k€149k▲
Current portion of amounts payable after more than one year42€40k€40k=
Trade debts44€63k€35k▼
Suppliers440/4€63k€35k▼
Taxes, remuneration and social security45€29k€33k▲
Taxes450/3€6k€9k▲
Remuneration and social security454/9€24k€24k▲
Other amounts payable47/48-€40k
Income statement
Code20232024
Remuneration, social security and pensions62€188k€193k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€106k€104k▼
Other operating charges640/8€6k€6k▲
Gross operating margin9900€304k€362k▲
Operating profit (loss)9901€4k€59k▲
Financial income75/76B€134€1▼
Recurring financial income75€134€1▼
Financial charges65/66B€10k€10k▼
Recurring financial charges65€10k€10k▲
Non-recurring financial charges66B€159-
Profit (loss) for the period before taxes9903€-7k€49k▲
Income taxes67/77-€2k
Profit (loss) for the period9904€-7k€47k▲
Profit (loss) for the period to be appropriated9905€-7k€47k▲
Appropriation of the result
Profit (loss) to be appropriated9906€99k€146k▲
Profit (loss) brought forward from the previous period14P€106k€99k▼
Profit to be distributed694/7-€40k
Directors or managers695-€40k
Social balance
Average headcount (FTE)90872.42.4=
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €188k | €186k | €188k | €193k | ▲ 2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €14k | €64k | €87k | €106k | €104k | ▼ 2.0% |
| Other operating charges640/8 | - | €403 | €5k | €6k | €6k | ▲ 3.5% |
| Gross operating margin9900 | €154k | €259k | €314k | €304k | €362k | ▲ 19.1% |
| Operating profit (loss)9901 | €5k | €6k | €36k | €4k | €59k | ▲ 1,564% |
| Financial income75/76B | - | €53 | - | €134 | €1 | ▼ 99.3% |
| Recurring financial income75 | €9 | €53 | - | €134 | €1 | ▼ 99.3% |
| Financial charges65/66B | - | €10k | €10k | €10k | €10k | ▼ 1.0% |
| Recurring financial charges65 | €5k | €10k | €10k | €10k | €10k | ▲ 0.6% |
| Non-recurring financial charges66B | - | - | - | €159 | - | - |
| Profit (loss) for the period before taxes9903 | €924 | €-4k | €25k | €-7k | €49k | ▲ 823% |
| Income taxes67/77 | €1k | - | - | - | €2k | - |
| Profit (loss) for the period9904 | €-240 | €-4k | €25k | €-7k | €47k | ▲ 799% |
| Profit (loss) for the period to be appropriated9905 | €-240 | €-4k | €25k | €-7k | €47k | ▲ 799% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.18M | €1.21M | €1.45M | €1.40M | €1.38M | ▼ 1.2% |
| Fixed assets21/28 | €819k | €810k | €1.12M | €1.03M | €928k | ▼ 10.1% |
| Tangible fixed assets22/27 | €819k | €810k | €1.12M | €1.03M | €928k | ▼ 10.1% |
| Land and buildings22 | - | €418k | €401k | €385k | €369k | ▼ 4.2% |
| Plant, machinery and equipment23 | - | €386k | €716k | €647k | €559k | ▼ 13.6% |
| Furniture and vehicles24 | - | €7k | €3k | - | - | - |
| Financial fixed assets28 | €140 | €140 | €140 | €140 | €140 | = |
| Current assets29/58 | €364k | €398k | €325k | €367k | €455k | ▲ 23.9% |
| Stocks and contracts in progress3 | €169k | €181k | €197k | €217k | €223k | ▲ 2.9% |
| Stocks30/36 | - | €181k | €197k | €217k | €223k | ▲ 2.9% |
| Amounts receivable within one year40/41 | €138k | €36k | €42k | €52k | €61k | ▲ 17.2% |
| Trade receivables40 | - | €8k | €7k | €3k | €2k | ▼ 15.6% |
| Other amounts receivable41 | - | €28k | €34k | €49k | €58k | ▲ 19.1% |
| Cash at bank and in hand54/58 | €56k | €182k | €87k | €99k | €171k | ▲ 73.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.18M | €1.21M | €1.45M | €1.40M | €1.38M | ▼ 1.2% |
| Equity10/15 | €105k | €101k | €127k | €120k | €127k | ▲ 5.8% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €2k | €2k | €2k | €2k | €2k | = |
| Non-distributable reserves130/1 | - | - | - | €2k | - | - |
| Reserves not available under the articles1311 | - | - | - | €2k | - | - |
| Distributable reserves133 | - | €2k | €2k | - | €2k | - |
| Profit (loss) carried forward14 | €84k | €81k | €106k | €99k | €106k | ▲ 7.0% |
| Amounts payable17/49 | €1.08M | €1.11M | €1.32M | €1.28M | €1.26M | ▼ 1.8% |
| Amounts payable after more than one year17 | €908k | €988k | €1.19M | €1.15M | €1.11M | ▼ 3.5% |
| Financial debts170/4 | - | €517k | €477k | €437k | €397k | ▼ 9.2% |
| Other amounts payable178/9 | - | €471k | €711k | €711k | €711k | = |
| Amounts payable within one year42/48 | €171k | €117k | €131k | €132k | €149k | ▲ 12.6% |
| Current portion of amounts payable after more than one year42 | - | €40k | €40k | €40k | €40k | = |
| Trade debts44 | €113k | €47k | €62k | €63k | €35k | ▼ 43.4% |
| Suppliers440/4 | - | €47k | €62k | €63k | €35k | ▼ 43.4% |
| Taxes, remuneration and social security45 | - | €31k | €29k | €29k | €33k | ▲ 13.2% |
| Taxes450/3 | - | €6k | €4k | €6k | €9k | ▲ 58.2% |
| Remuneration and social security454/9 | - | €25k | €25k | €24k | €24k | ▲ 2.7% |
| Other amounts payable47/48 | - | - | - | - | €40k | - |
| Accrued charges and deferred income492/3 | - | €2k | - | - | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-240 | €-4k | €25k | €-7k | €47k | ▲ 799% |
| + Depreciation and write-downs630 | €14k | €64k | €87k | €106k | €104k | ▼ 2.0% |
| Operating cash flow (approximation) | €13k | €60k | €112k | €99k | €151k | ▲ 51.9% |
| Investment in fixed assets (approximation) | - | €-54k | €-397k | €-18k | €0 | ▲ 100% |
| Change in cash | - | €125k | €-95k | €12k | €72k | ▲ 500% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
04-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Back to profitnet €47k
Net result €47k after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
31-12
Financial
Weakest financial yearnet €-7k
Net result drops to €-7k, the lowest in the series; recovery starts the following year.
28-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Back to profitnet €25k
Net result €25k after 3 loss-making years.
27-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
28-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 89 days late
2019
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 31 days late
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
26-09
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 57 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nivelles · 1 establishment unit since 1996
Ground area
1,045 m²
Building footprint
345 m²
Volume, LiDAR
2,822 m³
2 parcels, Wallonia · tallest building 10.7 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Rue Sainte-Anne 8, 1400 Nivelles
since 19962.075.451.788
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25072B0346/00K005 | Wallonia | 974 m² | 1 · 305 m² | 10.7 m · 3 fl. |
| 25782D0145/00A000 | Wallonia | 71 m² | 1 · 40 m² | 10.2 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteNivelles2.075.451.788
Similar companies · same sector, comparable size
VIVAPHARMA
BE 0740.481.964
Oudergem · Eq €126,780
PIRET PHARMA
BE 0783.830.868
Charleroi · Eq €126,674
Ilse Verstraeten
BE 0834.826.540
Sint-Truiden · Eq €126,672
APOTEEK DE SMEDT
BE 0414.478.228
Asse · Eq €126,967
BUDIN-CONSERVA
BE 0870.657.449
Roeselare · Eq €127,072
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,523 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded20-12-1995
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.